Daily use is positioned as simple: one serving provides targeted probiotics plus a prebiotic fiber to help those strains thrive
Perhaps the largest study was a 10-year analysis of 17,099 propensity score-matched patient pairs with type 2 diabetes, with or without AD, between 2015 and 2025, including pairs treated with GLP-1RAs
So they say, 'Let me log into one of these things, pay a fee and get my medication quick and be on my way.' I wish it were that easy
The hype is enormous -- which is exactly why I want to give you a clear-eyed, physician's take on what we actually know, what we don't, and what a responsible approach to this peptide looks like
Is any compounded GLP-1 medication still legal in 2026
Major guidelines recommend GLP-1RAs as first-line therapy in patients with T2D who have, or are at high risk for, atherosclerotic cardiovascular disease, chronic kidney disease (CKD), or obesity